Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis

Fig. 1

Synthesis of survival outcomes by baseline ctDNA status. A Individual patient data (IPD)-based disease-free survival (DFS) by baseline ctDNA status (+ vs. −). B IPD-based DFS by baseline ctDNA status (+ vs. −) based on propensity score matching (PSM). C IPD-based overall survival (OS) by baseline ctDNA status (+ vs. −). D Pooled meta-analysis of DFS by baseline ctDNA status (+ vs. −)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us